Categories
eleven News

Fidia Pharma USA Inc to exhibit at 2011 ACR/ARHP Annual Scientific Meeting

Fidia Pharma USA Inc will be exhibiting at the forthcoming Annual Scientific Meeting of the American College of Rheumatology in Chicago, 5-9 November 2011. Please come and see us at booth 1032.

We will be exhibiting our flagship product HYALGAN® (sodium hyaluronate, intra-articular injections for the treatment of pain in osteoarthritis of the knee.

HYALGAN® is a treatment option for people who do not get adequate pain relief from simple painkillers (like Tylenol® or Advil®) or from exercise and physical therapy. HYALGAN® injections can be used in addition to prescription pain relievers (like Celebrex®).

Our Four Leading Principles:

Innovation

Quality

Globalization

Competitiveness